Mistral expects to file these products with Health Canada during 2008. The company estimates that these products target a total market of more than $50 million.
Dalal Manoli, vice president, sales & marketing at Mistral, said: “We are very excited to file these six additional products with Health Canada in 2008. This will strengthen our position as a specialty pharma company with a focus on hospital products.”